Binge Eating Disorder
📧 Sign up to get email alerts when something new happens for Binge Eating Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Training App for Inhibitory Control Towards Food [NA]
An ongoing clinical trial from the University of Padova is evaluating a training app designed to improve inhibitory control toward food to h…
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: Sleep and Activity For Eating Disorders [NA]
A clinical trial is planned to study sleep and activity interventions for eating disorders, including anorexia nervosa, bulimia nervosa, and…
-
CLINICAL_TRIALS trial_result · 2025-12-18Clinical Trial Update: The Role of the Circadian System in Binge Eating Disorder [NA]
This clinical trial update reports that the study NCT04724668, exploring the role of the circadian system in binge eating disorder, has comp…
-
CLINICAL_TRIALS trial_result · 2025-12-18Clinical Trial Update: Low Intensity Focused Ultrasound for Binge Eating Disorder [NA]
The clinical trial evaluating low intensity focused ultrasound for binge eating disorder is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-12-17Clinical Trial Update: Cognitive-Behavioral and Pharmacologic (LDX) Treatment of Binge-Eating Disorder and Obesity: Maintenance Treatment [Phase 3]
Phase 3 maintenance trial evaluating cognitive-behavioral therapy combined with lisdexamfetamine (LDX) for binge-eating disorder and obesity…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-12-17Clinical Trial Update: Cognitive-Behavioral and Pharmacologic (LDX) Treatment of Binge-Eating Disorder and Obesity: Medication Change for Non-Responders [Phase 2, Phase 3]
A Phase 2/3 clinical trial update reports a medication change for non-responders in a cognitive-behavioral plus pharmacologic treatment appr…
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: Trial to Optimize Just-in-Time Adaptive Intervention for Binge Eating & Weight-related Behaviors [NA]
Clinical trial update for NCT06349460: an active, non-recruiting Northwestern University study evaluating a just-in-time adaptive interventi…
-
CLINICAL_TRIALS research · 2025-12-12Clinical Trial Update: Cognitive Training for Patients With Eating Disorders [NA]
A clinical trial update describes the status of a cognitive training intervention for eating disorders, including anorexia nervosa, bulimia …
-
CLINICAL_TRIALS research · 2025-12-10Clinical Trial Update: Project THINK: Trajectories of Health, Ingestive Behaviors, and Neurocognition in Kids
Clinical trial update for Project THINK studying health trajectories, ingestive behaviors, and neurocognition in children. The study is curr…
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: Binge Eating Self-help for Teens ONLINE Pilot and Feasibility Study [NA]
This is an online self-help program for teens addressing binge eating, reported as a completed pilot and feasibility study by Yale Universit…
-
CLINICAL_TRIALS trial_result · 2025-11-25Clinical Trial Update: Pilot Study on BP1.4979 Effect on Binge Eating Disorders [Phase 2]
Phase 2 pilot study evaluating BP1.4979 for binge-eating disorder has completed.
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: Building an Equitable and Accessible System of Eating Disorder Care for VA, DoD, and Underrepresented Americans [NA]
This clinical trial update describes an ongoing effort to build an equitable and accessible eating disorder care system for veterans, DoD pe…
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: Naltrexone Neuroimaging in Teens With Eating Disorders [EARLY_Phase 1]
An early-phase clinical trial is investigating neuroimaging of naltrexone in adolescents with eating disorders and binge eating; the study i…
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: Open-Label Safety Study of Solriamfetol in Subjects With Binge Eating Disorder [Phase 3]
An open-label Phase 3 safety study of solriamfetol for binge eating disorder is currently enrolling by invitation.
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Eating Disorder Using Solriamfetol [Phase 3]
Phase 3 trial recruiting to evaluate solriamfetol's effects on binge eating disorder by modulating TAAR-1, dopamine, and norepinephrine path…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: A Study of the Effects of Oxytocin in Adults With Binge-eating Disorder [Phase 2]
Phase 2 clinical trial evaluating the effects of oxytocin in adults with binge-eating disorder; currently recruiting.
-
CLINICAL_TRIALS research · 2025-11-04Clinical Trial Update: Combining Digital Cognitive-behavior Therapy With Mindfulness Training for Binge Eating Disorder [NA]
This clinical trial investigates digital cognitive-behavioral therapy combined with mindfulness training for binge eating disorder and is cu…
-
CLINICAL_TRIALS research · 2025-10-20Clinical Trial Update: Testing SHAPE: A Single-Session Intervention Targeting Binge Eating in Women Through Assessment and Values-Based Strategies [NA]
This clinical trial investigates SHAPE, a single-session behavioral intervention for binge eating in women that uses assessment and values-b…
-
CLINICAL_TRIALS trial_result · 2025-10-06Clinical Trial Update: Using Visual Feedback to Influence Rapid Response in the Treatment of Eating Disorders [NA]
The clinical trial investigating the use of visual feedback to influence rapid response in treating eating disorders has been terminated.
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: Web-based Guided Self-help CBT-E vs Online G-CBT-E for Binge Eating Behavior [NA]
Clinical trial evaluating web-based guided self-help CBT-E versus online G-CBT-E for binge eating disorder is currently enrolling by invitat…
-
CLINICAL_TRIALS trial_result · 2025-09-30Clinical Trial Update: Analysis of the Glycemic Profile of People Suffering From Compulsive Eating Disorders Aiming to Offer an Innovative Nutritional Approach (GLUCOPULSE) [NA]
This completed GLUCOPULSE trial update analyzes the glycemic profile of individuals with bulimia nervosa and binge eating disorder to explor…
-
FDA approval · 2025-09-23FDA Approved: VYVANSE — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for Vyvanse (lisdexamfetamine dimesylate) from Takeda Pharmaceuticals America, expanding the approve…
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: Efficacy and Safety of Tirzepatide Versus Placebo or Lisdexamfetamine Dimesylate for Binge-Eating Disorder [Phase 2]
A Phase 2 clinical trial is evaluating the efficacy and safety of tirzepatide versus placebo or lisdexamfetamine dimesylate for binge-eating…
-
CLINICAL_TRIALS trial_result · 2025-09-17Clinical Trial Update: EXOMIND (BTL-995) for Reduction of Binge-eating [NA]
Clinical trial update indicating a completed study evaluating EXOMIND (BTL-995) for reducing binge eating in individuals with Binge Eating D…
-
CLINICAL_TRIALS trial_result · 2025-09-17Clinical Trial Update: EXOMIND (BTL-995) for the Reduction of Binge-eating [NA]
A completed clinical trial evaluating EXOMIND (BTL-995) for reducing binge eating. The study includes individuals with binge eating and bing…